Online pulmonary rehabilitation for patients with chronic obstructive pulmonary disease (COPD) was found to be as effective as face-to-face rehabilitation programmes at improving patients’ exercise capacity and symptom control, according to new research.
“For many patients, attending classes in person isn’t easy and we know that attendance rates are variable,” said Tom Wilkinson of the Southampton University Faculty of Medicine. “This study challenges the paradigm that pulmonary rehabilitation needs to be delivered using a conventional face-to-face class-based approach.”
The study involved 90 patients with moderate COPD who were referred for pulmonary rehabilitation. Study participants were assigned randomly to either online or face-to-face rehabilitation. Patients were well-matched between treatment arms for age, disease severity and smoking status. Approximately twice as many (n=64) study participants were assigned to the online group as were assigned to in-person classes (n=26). The researchers were blinded to which group each person was in.
Those in the face-to-face group participated in six-week group sessions at a local rehabilitation centre, while online subjects logged in to the MyPR application from their home computers. MyPR, which is part of the MyCOPD software application, is the first to be supported in the UK by the National Health Service Innovation and Technology tariff, and is free for patients with advanced COPD.
Outcome measures for the study were patients’ six-minute walking distance and scores on the COPD Assessment Test (CAT). At the completion of the study, the walking distance for online participants was not significantly less than for face-to-face study subjects. Improvements in pulmonary rehabilitation scores on the CAT were higher for the online group in all domains.
“This study has shown that MyPR is non-inferior to usual pulmonary rehab for key improvements in exercise capacity and symptom control,” said Wilkinson. “This effect was seen with minimal clinician involvement in the online arm, demonstrating that digitally supported pulmonary rehabilitation is both safe and effective.”
“Further studies are needed to explore how, during implementation, the platform can be best used in blended digital services. Research should also examine the benefits of use of MyPR over the long term, as the app, unlike face-to-face classes, can deliver maintenance pulmonary rehabilitation at minimal cost.”
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.
